Dopamine, Parkinson's disease, and volition

被引：2
|
作者：
Horvitz, JC [1 ]
机构：
[1] Columbia Univ, Dept Psychol, New York, NY 10027 USA
来源：
BEHAVIORAL AND BRAIN SCIENCES | 2002年 / 25卷 / 05期
关键词：
D O I：
10.1017/S0140525X02300104
中图分类号：
B84 [心理学];
学科分类号：
04 ; 0402 ;
摘要：
Disruptions in dopamine transmission within the basal ganglia (BG) produce deficits in voluntary actions, that is, in the interface between cortically-generated goal representation and BG-mediated response selection. Under conditions of dopamine loss in humans and other annuals, responses are impaired when they require internal generation, but are relatively intact when elicited by external stimuli.
引用
收藏
页码：586 / +
页数：7
相关论文
共 50 条
  • [41] Creativity induced by dopamine agonists in Parkinson's disease
    Batir, A.
    Lhommee, E.
    Ardouin, C.
    Fraix, V.
    Seigneuret, E.
    Chabardes, S.
    Benabid, A. -L.
    Pollak, P.
    Krack, P.
    MOVEMENT DISORDERS, 2009, 24 : S234 - S234
  • [42] Impaired dopamine metabolism in Parkinson's disease pathogenesis
    Masato, Anna
    Plotegher, Nicoletta
    Boassa, Daniela
    Bubacco, Luigi
    MOLECULAR NEURODEGENERATION, 2019, 14 (01)
  • [43] The role of inflammation and dopamine synthesis in Parkinson's disease
    Ong, L. K.
    Briggs, G. D.
    Dunkley, P. R.
    Dickson, P. W.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 40 - 40
  • [44] Dopamine agonist treatment of Parkinson's disease in the elderly
    Isaacson, SH
    Kreitzman, DL
    MOVEMENT DISORDERS, 2004, 19 : S266 - S266
  • [45] WITHDRAWAL OF DOPAMINE AGONISTS IN PATIENTS WITH PARKINSON'S DISEASE
    Cunnington, A-L
    Hood, K.
    White, L.
    AGE AND AGEING, 2011, 40 : II63 - II63
  • [46] Dopamine agonist treatment of Parkinson's disease in the elderly
    Isaacson, SH
    Raton, B
    Isaacson, RS
    Kreitzman, DL
    NEUROLOGY, 2005, 64 (06) : A107 - A107
  • [47] Optimizing the use of dopamine agonists in Parkinson's disease
    Olanow, C. Warren
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 316 - 316
  • [48] Dopamine agonists: their role in the treatment of Parkinson's disease
    Brooks, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06): : 685 - 689
  • [49] Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease
    Roy, Subhojit
    NATURE NEUROSCIENCE, 2017, 20 (11) : 1514 - 1515
  • [50] Dopamine agonist therapy in early Parkinson's disease
    Stowe, R. L.
    Ives, N. J.
    Clarke, C.
    van, Hilten J.
    Ferreira, J.
    Hawker, R. J.
    Shah, L.
    Wheatley, K.
    Gray, R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
12345